Adicet Bio, Inc.
ACET
$0.537
$0.089920.11%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -117.12M | -117.88M | -137.29M | -139.79M | -142.66M |
| Total Depreciation and Amortization | 6.47M | 6.53M | 6.59M | 6.50M | 6.10M |
| Total Amortization of Deferred Charges | 39.00K | 40.00K | 41.00K | 52.00K | 30.00K |
| Total Other Non-Cash Items | 23.76M | 26.22M | 44.69M | 43.69M | 42.56M |
| Change in Net Operating Assets | -5.53M | -6.67M | -5.02M | -2.92M | 252.00K |
| Cash from Operations | -92.38M | -91.76M | -91.00M | -92.47M | -93.72M |
| Capital Expenditure | -1.12M | -1.08M | -1.58M | -2.79M | -4.46M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -118.12M | -- | -- | -- | -- |
| Cash from Investing | -119.24M | -1.08M | -1.58M | -2.79M | -4.46M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 207.63M | 111.47M | 111.47M | 111.49M | 386.00K |
| Repurchase of Common Stock | -96.32M | -96.40M | -281.00K | -281.00K | -150.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 111.31M | 15.07M | 111.19M | 111.21M | 236.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.31M | -77.78M | 18.61M | 15.95M | -97.95M |
